hero-line-left hero-line-top

Powering precision medicine with insights from a global oncology network

Syapse partners with health systems, life sciences companies, and regulators to deliver clinical, programmatic, and research insights from the world’s largest network of health systems focused on precision medicine.

hero-line-bottom
hero-line-horizontal
icon-line icon

Get the Right Therapy

We help health systems operationalize precision medicine to deliver the right therapies to the right patients.

icon-line icon

Get the Therapy Right

We help life sciences companies speed the time to approval for new therapies or label expansions.

icon-line icon

Get the Evidence Right

We help regulators shape standards for the creation and use of real-world evidence in oncology.

What's new

Syapse Deepens Scientific and Technical Expertise with Key Additions to Leadership Team

SAN FRANCISCO, Calif., August 6, 2020 — Syapse®, a real-world evidence company accelerating the delivery of precision medicine through…

Read

Blog

FDA Commissioner Stephen Hahn, MD, testifies before the House Energy and Commerce Committee on his agency’s response to the pandemic.

“We have learned that we need to collect real-world evidence in real-time during an emergency … to inform decisions and how we could change them moving forward, so your support for real-world evidence generation would be incredibly helpful,” Hahn said.

Read

Let’s talk

If you’d like to learn more about Syapse, tell us a little about yourself and we will reach out as soon as possible.